In the context of cancer therapy, blocking the mobilization of hematopoietic stem/ progenitor cell by inhibiting EphB4-ephrin-B2 communication also resulted in reduced infiltration of the hematopoietic stem/progenitor cells into murine tumor models (Kwak et al., 2016) (Figure 4). The gene discussed is EFNB2; the disease is neoplasm.